Scarica l'app Stockscreener
3.75
9.33%
0.32
Skye Bioscience Inc Borsa (SKYE) Ultime notizie
(01/30/25) Top Picks 2025: Skye Bioscience (SKYE) - Moneyshow.com
Cantor Fitzgerald Estimates Skye Bioscience FY2025 Earnings - MarketBeat
Cantor Fitzgerald Forecasts Skye Bioscience FY2025 Earnings - Defense World
Cantor Fitzgerald Predicts Skye Bioscience FY2025 Earnings - Defense World
Barclays PLC Has $226,000 Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Barclays PLC Has $226,000 Stock Holdings in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Skye Bioscience (NASDAQ:SKYE) Trading Down 2.5%Should You Sell? - MarketBeat
12,200 Shares in Skye Bioscience, Inc. (NASDAQ:SKYE) Acquired by Jane Street Group LLC - Defense World
Jane Street Group LLC Invests $48,000 in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Skye Bioscience targets Q4 for obesity drug data - Investing.com India
Skye Bioscience Provides 2025 Look Ahead and Year in Review - The Manila Times
Skye Bioscience Sets Major 2025 Milestones for Revolutionary Obesity Drug Trial - StockTitan
Financial Analysis: Skye Bioscience (NASDAQ:SKYE) vs. VYNE Therapeutics (NASDAQ:VYNE) - Defense World
Geode Capital Management LLC Purchases 15,614 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Acquired by Geode Capital Management LLC - Defense World
Barclays PLC Increases Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Barclays PLC Buys 15,551 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
State Street Corp Acquires 23,201 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
State Street Corp Increases Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Skye Bioscience (NASDAQ:SKYE) Trading Down 3% – Should You Sell? - Defense World
Skye Bioscience (NASDAQ:SKYE) Shares Down 3% – Should You Sell? - Defense World
Skye Bioscience (NASDAQ:SKYE) Trading Down 3%Time to Sell? - MarketBeat
Skye Bioscience to Present at J.P. Morgan Healthcare Conference - GlobeNewswire
Skye Bioscience to Present at J.P. Morgan Healthcare Conference 2025: Spotlight on Obesity Treatment Pipeline - StockTitan
Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Bought by BNP Paribas Financial Markets - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Purchased by BNP Paribas Financial Markets - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Sees Significant Drop in Short Interest - MarketBeat
Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Average Recommendation of “Buy” from Analysts - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Skye Bioscience's SWOT analysis: nimacimab's potential in obesity stock market - Investing.com
Point72 Asset Management L.P. Has $1.63 Million Stock Holdings in Skye Bioscience, Inc. (NASDAQ:SKYE) - MarketBeat
Skye Bioscience: Nimacimab Targets Safer Weight Loss, Speculative Buy (NASDAQ:SKYE) - Seeking Alpha
Skye Bioscience (NASDAQ:SKYE) Shares Down 12.7%Should You Sell? - MarketBeat
Baker BROS. Advisors LP Purchases 934,634 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - MarketBeat
Baker BROS. Advisors LP Has $5.61 Million Holdings in Skye Bioscience, Inc. (NASDAQ:SKYE) - MarketBeat
Skye Bioscience, Inc. (NASDAQ:SKYE) Short Interest Up 26.8% in November - MarketBeat
Craig-Hallum Initiates Coverage of Skye Bioscience (SKYE) with Buy Recommendation - MSN
Top 10 startups in Ophthalmology in San Diego, United States in Nov, 2024 - Tracxn
Don't Ignore The Insider Selling In Skye Bioscience - Simply Wall St
Skye Bioscience chief development officer sells shares worth $97,721 By Investing.com - Investing.com South Africa
Skye Bioscience chief development officer sells shares worth $97,721 - Investing.com India
Skye Bioscience CEO Punit Dhillon sells $413,924 in stock By Investing.com - Investing.com Nigeria
Skye Bioscience CFO Kaitlyn Arsenault sells $216,652 in stock By Investing.com - Investing.com Australia
Skye Bioscience CFO Kaitlyn Arsenault sells $216,652 in stock - Investing.com India
Skye Bioscience CEO Punit Dhillon sells $413,924 in stock - Investing.com India
Skye Bioscience director Grayson Paul A. sells $432,061 in stock By Investing.com - Investing.com Canada
Skye Bioscience director Grayson Paul A. sells $432,061 in stock - Investing.com
5.49%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):